Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00615_DB06414> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00615_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00615_DB06414 label "DDI between Rifabutin and Etravirine - Etravirine may experience a decrease in serum concentration. It is recommended to monitor etravirine therapy for efficacy. The combination of rifabutin and etravirine therapy is contraindicated if a protease inhibitor which is ritonavir boosted is also being used. [drugbank_resource:DB00615_DB06414]" assertion.
- drugbank_resource:DB00615_DB06414 identifier "drugbank_resource:DB00615_DB06414" assertion.
- drugbank_resource:DB00615_DB06414 title "DDI between Rifabutin and Etravirine - Etravirine may experience a decrease in serum concentration. It is recommended to monitor etravirine therapy for efficacy. The combination of rifabutin and etravirine therapy is contraindicated if a protease inhibitor which is ritonavir boosted is also being used." assertion.